Deutsch Intern
Institute for Clinical Epidemiology and Biometry

Prof. Dr. Dr. Götz Gelbrich

Prof. Dr. Dr. Götz Gelbrich

Phone: +49 931 / 201 46409
Fax: +49 931 / 201 647310
E-Mail: goetz.gelbrich@klinik.uni-wuerzburg.de

short CV

since 2012 Professor (W2) of biometry and deputy of the Institute of Clinical Epidemiology and Biometry, University of Würzburg
2011 Venia legendi for Medical Biometry and Epidemiology, University Leipzig
2008 2nd doctoral degree (Dr. rer. med., summa cum laude), University of Leipzig
since 2003 senior biometrician of the German Competence Network Heart Failure
1999-2012 Biometrician at the Clinical Trial Centre Leipzig, University of Leipzig
1995 Doctoral Thesis Award, University of Greifswald
1994             1st doctoral degree (Dr. rer. nat., summa cum laude) University of Greifswald
1990-1999 assistant at the Institute of Mathematics and Informatics, University of Greifswald
1990 mgr matematyki (with distinction), Warsaw University
1985-1990 diploma study of mathematics, Warsaw University

Research interests

Biometry, clinical trials, study design, clinical epidemiology


Main Publications in recent years

2023[ to top ]
  • Gelbrich G, Morbach C, Deutschbein T, Fassnacht M, Störk S, Heuschmann PU. The Population Comparison Index: An Intuitive Measure to Calibrate the Extent of Impairments in Patient Cohorts in Relation to Healthy and Diseased Populations. Int J Environ Res Public Health. 2023;20(3).
2022[ to top ]
  • Erhardt A, Gelbrich G, Klinger-König J, Streit F, Kleineidam L, Riedel-Heller SG, Schmidt B, Schmiedek F, Wagner M, Grabe HJ, Rietschel M, Berger K, Deckert J. Generalised anxiety and panic symptoms in the German National Cohort (NAKO). World J Biol Psychiatry. 2022;:1-16.
  • Kleineidam L, Stark M, Riedel-Heller SG, Pabst A, Schmiedek F, Streit F, Rietschel M, Klinger-König J, Grabe HJ, Erhardt A, Gelbrich G, Schmidt B, Berger K, Wagner M. The assessment of cognitive function in the German National Cohort (NAKO) - Associations of demographics and psychiatric symptoms with cognitive test performance. World J Biol Psychiatry. 2022;:1-15.
  • Morbach C, Hoffmann K, Sahiti F, Detomas M, Eichner F, Kroiss M, Gelbrich G, Frantz S, Fassnacht M, Heuschmann P, Hahner S, Stoerk S, Deutschbein T. Mild autonomous cortisol secretion portends similar cardiac compromise as overt endogenous Cushings syndrome. European Heart Journal - Cardiovascular Imaging [Internet]. 2022;23(Supplement_1). Available from: https://doi.org/10.1093/ehjci/jeab289.178
  • Sahiti F, Morbach C, Ehrlich K, Detomas M, Kroiss M, Lengenfelder B, Gelbrich G, Frantz S, Fassnacht M, Heuschmann P, Hahner S, Stoerk S, Deutschbein T. Endogenous Cushings syndrome is associated with impaired myocardial work efficiency. European Heart Journal - Cardiovascular Imaging [Internet]. 2022;23(Supplement_1). Available from: https://doi.org/10.1093/ehjci/jeab289.166
2021[ to top ]
  • Sahiti F, Morbach C, Cejka V, Albert J, Eichner FA, Gelbrich G, Heuschmann PU, Störk S. Left Ventricular Remodeling and Myocardial Work: Results From the Population-Based STAAB Cohort Study. Front Cardiovasc Med. 2021;8:669335.
  • Yurdadogan T, Malsch C, Kotseva K, Wood D, Leyh R, Ertl G, Karmann W, Müller-Scholden L, Morbach C, Breunig M, Wagner M, Gelbrich G, Bots ML, Heuschmann PU, Störk S. Functional versus morphological assessment of vascular age in patients with coronary heart disease. Scientific Reports [Internet]. 2021;11(1):18164. Available from: https://doi.org/10.1038/s41598-021-96998-x
  • Sahiti F, Morbach C, Cejka V, Tiffe T, Wagner M, Eichner FA, Gelbrich G, Heuschmann PU, Störk S. Impact of cardiovascular risk factors on myocardial work—insights from the STAAB cohort study. Journal of Human Hypertension [Internet]. 2021;36(3):235-4. Available from: https://doi.org/10.1038/s41371-021-00509-4
  • Morbach C, Gelbrich G, Tiffe T, Eichner FA, Christa M, Mattern R, Breunig M, Cejka V, Wagner M, Heuschmann PU, Störk S, consortium the S. Prevalence and determinants of the precursor stages of heart failure: results from the population-based STAAB cohort study. European Journal of Preventive Cardiology [Internet]. 2021;28(9):924-3. Available from: https://doi.org/10.1177/2047487320922636
  • Lange F, Roothans J, Wichmann T, Gelbrich G, Röser C, Volkmann J, Reich M. DIPS (Dystonia Image-based Programming of Stimulation: a prospective, randomized, double-blind crossover trial). Neurological Research and Practice [Internet]. 2021;3(1):65. Available from: https://doi.org/10.1186/s42466-021-00165-6
  • Horn A, Krist L, Lieb W, Montellano FA, Kohls M, Haas K, Gelbrich G, Bolay-Gehrig SJ, Morbach C, Reese JP, Störk S, Fricke J, Zoller T, Schmidt S, Triller P, Kretzler L, Rönnefarth M, Von Kalle C, Willich SN, Kurth F, Steinbeis F, Witzenrath M, Bahmer T, Hermes A, Krawczak M, Reinke L, Maetzler C, Franzenburg J, Enderle J, Flinspach A, Vehreschild J, Schons M, Illig T, Anton G, Ungethüm K, Finkenberg BC, Gehrig MT, Savaskan N, Heuschmann PU, Keil T, Schreiber S. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection. 2021;49(6):1277-8.
  • Fleischer A, Heimeshoff L, Allgaier J, Jordan K, Gelbrich G, Pryss R, Schobel J, Einsele H, Kortuem M, Maatouk I, Weinhold N, Rasche L. Is PFS the Right Endpoint to Assess Outcome of Maintenance Studies in Multiple Myeloma? Results of a Patient Survey Highlight Quality-of-Life As an Equally Important Outcome Measure. Blood [Internet]. 2021;138:836. Available from: https://www.sciencedirect.com/science/article/pii/S000649712102824X
  • Eichner FA, Gelbrich G, Weißbrich B, Dölken L, Kurzai O, Deckert J, Ertl G, Barth M, Hein G, Neuhauser H. Seroprävalenz von COVID-19 und psychosoziale Auswirkungen in der Allgemeinbevölkerung: Ergebnisse des STAAB-COVID-One Programms. Das Gesundheitswesen. 2021;83(12):965-7.
2020[ to top ]
  • Gelbrich B, Carl C, Gelbrich G. Comparison of three methods to estimate dental age in children. Clin Oral Investig. 2020;24(7):2469-75.
  • Morbach C, Sahiti F, Tiffe T, Cejka V, Eichner FA, Gelbrich G, Heuschmann PU, Störk S. Myocardial work - correlation patterns and reference values from the population-based STAAB cohort study. PLoS One. 2020;15(10):e0239684.
  • Schlagenhauf U, Rehder J, Gelbrich G, Jockel-Schneider Y. Consumption of Lactobacillus reuteri-containing lozenges improves periodontal health in navy sailors at sea: A randomized controlled trial. Journal of Periodontology [Internet]. 2020;91(10):1328-3. Available from: https://aap.onlinelibrary.wiley.com/doi/abs/10.1002/JPER.19-0393
  • Wasser K, Weber-Krüger M, Gröschel S, Uphaus T, Liman J, Hamann GF, Kermer P, Seegers J, Binder L, Gelbrich G, Gröschel K, Wachter R. Brain Natriuretic Peptide and Discovery of Atrial Fibrillation After Stroke. Stroke [Internet]. 2020;51(2):395-401. Available from: https://www.ahajournals.org/doi/abs/10.1161/STROKEAHA.119.026496
2019[ to top ]
  • Müller-Scholden L, Kirchhof J, Morbach C, Breunig M, Meijer R, Rücker V, Tiffe T, Yurdadogan T, Wagner M, Gelbrich G, Bots ML, Störk S, Heuschmann PU. Segment-specific association of carotid-intima-media thickness with cardiovascular risk factors - findings from the STAAB cohort study. BMC Cardiovasc Disord. 2019;19(1):84.
  • Tiffe T, Morbach C, Malsch C, Gelbrich G, Wahl V, Wagner M, Kotseva K, Wood D, Leyh R, Ertl G, Karmann W, Störk S, Heuschmann PU. Physicians’ lifestyle advice on primary and secondary cardiovascular disease prevention in Germany: A comparison between the STAAB cohort study and the German subset of EUROASPIRE IV. Eur J Prev Cardiol. 2019;:2047487319838218.
  • Tiffe T, Morbach C, Rücker V, Gelbrich G, Wagner M, Faller H, Störk S, Heuschmann PU. Impact of Patient Beliefs on Blood Pressure Control in the General Population: Findings from the Population-Based STAAB Cohort Study. Int J Hypertens. 2019;2019:9385397.
  • Morbach C, Gelbrich G, Tiffe T, Eichner F, Wagner M, Heuschmann PU, Störk S, Frantz S, Maack C, Ertl G, Fassnacht M, Wanner C, Leyh R, Volkmann J, Deckert J, Faller H, Jahns R. Variations in cardiovascular risk factors in people with and without migration background in Germany – Results from the STAAB cohort study. International Journal of Cardiology [Internet]. 2019;286:186-9. Available from: https://www.sciencedirect.com/science/article/pii/S0167527318341305
  • Morbach C, Walter BN, Breunig M, Liu D, Tiffe T, Wagner M, Gelbrich G, Heuschmann PU, Störk S. Speckle tracking derived reference values of myocardial deformation and impact of cardiovascular risk factors - Results from the population-based STAAB cohort study. PLoS One. 2019;14(9):e0221888.
  • Diekmann S, Hörster L, Evers S, Hiligsmann M, Gelbrich G, Gröschel K, Wachter R, Hamann GF, Kermer P, Liman J, Weber-Krüger M, Wasem J, Neumann A. Economic evaluation of prolonged and enhanced ECG Holter monitoring in acute ischemic stroke patients. Current Medical Research and Opinion [Internet]. 2019;35(11):1859-66. Available from: https://doi.org/10.1080/03007995.2019.1646000
  • Dufner V, Sayehli CM, Chatterjee M, Hummel HD, Gelbrich G, Bargou RC, Goebeler ME. Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab. Blood Advances [Internet]. 2019;3(16):2491-8. Available from: https://doi.org/10.1182/bloodadvances.2019000025
2018[ to top ]
  • Löhr M, Freitag B, Technau A, Krauss J, Monoranu CM, Rachor J, Lutz MB, Hagemann C, Kessler AF, Linsenmann T, Wölfl M, Ernestus RI, Engelhardt S, Gelbrich G, Schlegel PG, Eyrich M. High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T(reg) depletion. Cancer Immunol Immunother. 2018;67(10):1545-58.
  • Weber-Krueger M, Gelbrich G, Liman J, Hamann GF, Kermer P, Gröschel K, Wachter R. Abstract WP201: Stroke Patients With Atrial Fibrillation Detected by 72 hour- versus Prolonged ECG-monitoring. Stroke [Internet]. 2018;49(Suppl_1):AWP201-AWP201. Available from: https://www.ahajournals.org/doi/abs/10.1161/str.49.suppl_1.WP201
  • Wagner M, Gelbrich G, Kircher J, Kotseva K, Wood D, Morbach C, Leyh R, Ertl G, Karmann W, Störk S, Heuschmann PU. Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey. Int J Behav Med. 2018;25(3):283-9.
  • Krone M, Dufner V, Wagner M, Gelbrich G, Ertl G, Heuschmann PU. Public funding for medical research in relation to the burden of disease caused by cardiovascular diseases and neoplasms in Germany. Clin Res Cardiol. 2018;107(9):737-44.
  • Morbach C, Gelbrich G, Breunig M, Tiffe T, Wagner M, Heuschmann PU, Störk S. Impact of acquisition and interpretation on total inter-observer variability in echocardiography: results from the quality assurance program of the STAAB cohort study. The International Journal of Cardiovascular Imaging [Internet]. 2018;34(7):1057-65. Available from: https://doi.org/10.1007/s10554-018-1315-3
  • Bobenko A, Bartels I, Münch M, Trippel T, Lindhorst R, Nolte K, Herrmann-Lingen C, Halle M, Duvinage A, Düngen HD, Gelbrich G, Tschöpe C, Hasenfuss G, Wachter R, Pieske B, Edelmann F. Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction. ESC Heart Failure [Internet]. 2018;5(1):53-62. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.12227
2017[ to top ]
  • Tiffe T, Wagner M, Rücker V, Morbach C, Gelbrich G, Störk S, Heuschmann PU. Control of cardiovascular risk factors and its determinants in the general population- findings from the STAAB cohort study. BMC Cardiovasc Disord. 2017;17(1):276.
  • Wachter R, Gröschel K, Gelbrich G, Hamann GF, Kermer P, Liman J, Seegers J, Wasser K, Schulte A, Jürries F, Messerschmid A, Behnke N, Gröschel S, Uphaus T, Grings A, Ibis T, Klimpe S, Wagner-Heck M, Arnold M, Protsenko E, Heuschmann PU, Conen D, Weber-Krüger M. Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AF(RANDOMISED)): an open-label randomised controlled trial. Lancet Neurol. 2017;16(4):282-90.
2016[ to top ]
  • Lange J, Weil F, Riegler C, Groeber F, Rebhan S, Kurdyn S, Alb M, Kneitz H, Gelbrich G, Walles H, Mielke S. Interactions of donor sources and media influence the histo-morphological quality of full-thickness skin models. Biotechnol J. 2016;11(10):1352-61.
  • Jahandar Lashki D, Zelenak C, Tahirovic E, Trippel TD, Kolip P, Busjahn A, Rauchfuß M, Nolte K, Schwarz S, Wachter R, Gelbrich G, Halle M, Pieske B, Herrmann-Lingen C, Edelmann F, Düngen HD. [Assessment of subjective physical well-being in heart failure : Validation of the FEW16 questionnaire]. Herz. 2016;42(2):200-8.
  • Musacchio T, Purrer V, Papagianni A, Fleischer A, Mackenrodt D, Malsch C, Gelbrich G, Steigerwald F, Volkmann J, Klebe S. Non-Motor Symptoms of Essential Tremor Are Independent of Tremor Severity and Have an Impact on Quality of Life. Tremor Other Hyperkinet Mov (N Y). 2016;6:361.
  • Hummel M, Perez J, Hagen R, Gelbrich G, Ernestus RI, Matthies C. Auditory Monitoring in Vestibular Schwannoma Surgery: Intraoperative Development and Outcome. World Neurosurg. 2016;96:444-53.
  • Hummel M, Perez J, Hagen R, Gelbrich G, Ernestus RI, Matthies C. When Does Hearing Loss Occur in Vestibular Schwannoma Surgery? Importance of Auditory Brainstem Response Changes in Early Postoperative Phase. World Neurosurg. 2016;95:91-8.
  • Angermann CE, Gelbrich G, Störk S, Gunold H, Edelmann F, Wachter R, Schunkert H, Graf T, Kindermann I, Haass M, Blankenberg S, Pankuweit S, Prettin C, Gottwik M, Böhm M, Faller H, Deckert J, Ertl G, Members MHSI, Committee. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial. Jama. 2016;315(24):2683-93.
  • Wagner M, Tiffe T, Morbach C, Gelbrich G, Störk S, Heuschmann PU, STAAB-Consortium. Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression - design and rationale of the STAAB cohort study. Eur J Prev Cardiol. 2016;24(5):468-79.
  • Edelmann F, Musial-Bright L, Gelbrich G, Trippel T, Radenovic S, Wachter R, Inkrot S, Loncar G, Tahirovic E, Celic V, Veskovic J, Zdravkovic M, Lainscak M, Apostolović S, Neskovic AN, Pieske B, Düngen HD, Failure CEI, in the Competence Network Heart PMT. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. JACC Heart Fail. 2016;4(2):140-9.
2015[ to top ]
  • Gelbrich B, Schwerdt S, Hirsch A, Dannhauer KH, Tausche E, Gelbrich G. Verschiedene Gesichter der Altersschätzung: Methodische Betrachtungen aus der Sicht einzelner Disziplinen. Rechtsmedizin. 2015;25:7-11.
  • Gelbrich B, Frerking C, Weiß S, Schwerdt S, Stellzig-Eisenhauer A, Tausche E, Gelbrich G. Combining wrist age and third molars in forensic age estimation: how to calculate the joint age estimate and its error rate in age diagnostics*. Annals of Human Biology [Internet]. 2015;42(4):389-96. Available from: https://doi.org/10.3109/03014460.2015.1046487
  • Güder G, Gelbrich G, Edelmann F, Wachter R, Pieske B, Pankuweit S, Maisch B, Prettin C, Brenner S, Morbach C, Berliner D, Deubner N, Ertl G, Angermann CE, Störk S, Germany CNHF. Reverse epidemiology in different stages of heart failure. Int J Cardiol. 2015;184:216-24.
  • Edelmann F, Holzendorf V, Wachter R, Nolte K, Schmidt AG, Kraigher-Krainer E, Duvinage A, Unkelbach I, Düngen HD, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Stough WG, Pieske BM. Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial. Eur J Heart Fail. 2015;17(2):214-23.
  • Faller H, Störk S, Gelbrich G, Schowalter M, Ertl G, Angermann CE. Depressive symptoms in heart failure: Independent prognostic factor or marker of functional status?. J Psychosom Res. 2015;78(6):569-72.
  • Dekleva M, Lazic JS, Soldatovic I, Inkrot S, Arandjelovic A, Waagstein F, Gelbrich G, Cvijanovic D, Dungen HD. Improvement of Ventricular-Arterial Coupling in Elderly Patients with Heart Failure After Beta Blocker Therapy: Results from the CIBIS-ELD Trial. Cardiovasc Drugs Ther. 2015;29(3):287-94.
  • Güder G, Störk S, Gelbrich G, Brenner S, Deubner N, Morbach C, Wallenborn J, Berliner D, Ertl G, Angermann CE. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling. Eur J Heart Fail. 2015;17(4):442-52.
  • Nolte K, Herrmann-Lingen C, Wachter R, Gelbrich G, Düngen HD, Duvinage A, Hoischen N, von Oehsen K, Schwarz S, Hasenfuss G, Halle M, Pieske B, Edelmann F. Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial. Eur J Prev Cardiol. 2015;22(5):582-93.
  • Piepenburg SM, Faller H, Gelbrich G, Störk S, Warrings B, Ertl G, Angermann CE. Comparative potential of the 2-item versus the 9-item patient health questionnaire to predict death or rehospitalization in heart failure. Circ Heart Fail. 2015;8(3):464-72.
  • Seegers J, Zabel M, Grüter T, Ammermann A, Weber-Krüger M, Edelmann F, Gelbrich G, Binder L, Herrmann-Lingen C, Gröschel K, Hasenfuß G, Feltgen N, Pieske B, Wachter R. Natriuretic peptides for the detection of paroxysmal atrial fibrillation. Open Heart [Internet]. 2015;2(1):e000182. Available from: http://openheart.bmj.com/content/2/1/e000182.abstract
  • Pankuweit S, Lüers C, Richter A, Ruppert V, Gelbrich G, Maisch BCNHF. Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy. Eur J Clin Invest. 2015;45(9):906-17.
  • Neumann A, Mostardt S, Biermann J, Gelbrich G, Goehler A, Geisler BP, Siebert U, Störk S, Ertl G, Angerrmann CE, Wasem J. Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study. Clin Res Cardiol. 2015;104(4):304-9.
  • Inkrot S, Lainscak M, Edelmann F, Loncar G, Stankovic I, Celic V, Apostolovic S, Tahirovic E, Trippel T, Herrmann-Lingen C, Gelbrich G, Düngen HD. Poor self-rated health predicts mortality in patients with stable chronic heart failure. Eur J Cardiovasc Nurs. 2015;15(7):504-12.
2014[ to top ]
  • Schneider A, Gutjahr-Lengsfeld L, Ritz E, Scharnagl H, Gelbrich G, Pilz S, Macdougall IC, Wanner C, Drechsler C. Longitudinal assessments of erythropoietin-stimulating agent responsiveness and the association with specific clinical outcomes in dialysis patients. Nephron Clin Pract. 2014;128(1-2):147-52.
  • Weber-Krüger M, Gelbrich G, Stahrenberg R, Liman J, Kermer P, Hamann GF, Seegers J, Gröschel K, Wachter R, investigators FA. Finding atrial fibrillation in stroke patients: Randomized evaluation of enhanced and prolonged Holter monitoring--Find-AF(RANDOMISED) --rationale and design. Am Heart J. 2014;168(4):438-445.e1.
  • Pilz S, Edelmann F, Meinitzer A, Gelbrich G, Döner U, Düngen HD, Tomaschitz A, Kienreich K, Gaksch M, Duvinage A, Stahrenberg R, Kunde J, Schmidt A, März W, Wachter R, Pieske B. Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction. J Card Fail. 2014;20(12):923-30.
  • Düngen HD, Musial-Bright L, Inkrot S, Apostolović S, Edelmann F, Lainščak M, Sekularac N, Störk S, Tahirovic E, Tscholl V, Krackhardt F, Loncar G, Trippel TD, Gelbrich G. Heart rate following short-term beta-blocker titration predicts all-cause mortality in elderly chronic heart failure patients: insights from the CIBIS-ELD trial. Eur J Heart Fail. 2014;16(8):907-14.
  • Matthies C, Brill S, Varallyay C, Solymosi L, Gelbrich G, Roosen K, Ernestus RI, Helms J, Hagen R, Mlynski R, Shehata-Dieler W, Müller J. Auditory brainstem implants in neurofibromatosis Type 2: is open speech perception feasible?. J Neurosurg. 2014;120(2):546-58.
  • Gelbrich G, Störk S, Kreißl-Kemmer S, Faller H, Prettin C, Heuschmann PU, Ertl G, Angermann CE. Effects of structured heart failure disease management on mortality and morbidity depend on patients’ mood: results from the Interdisciplinary Network for Heart Failure Study. Eur J Heart Fail. 2014;16(10):1133-41.
  • Apostolovic S, Stanojevic D, Lainscak M, Gelbrich G, Jankovic-Tomasevic R, Pavlovic M, Djordjevic-Radojkovic D, Salinger-Martinovic S, Putnikovic B, Radovanovic S, Waagstein F, Tomasevic M, Tahirovic E, Inkrot S, Musial-Bright L, Düngen HD. Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD). Cardiol J. 2014;21(3):265-72.
  • Meder B, Rühle F, Weis T, Homuth G, Keller A, Franke J, Peil B, Lorenzo Bermejo J, Frese K, Huge A, Witten A, Vogel B, Haas J, Völker U, Ernst F, Teumer A, Ehlermann P, Zugck C, Friedrichs F, Kroemer H, Dörr M, Hoffmann W, Maisch B, Pankuweit S, Ruppert V, Scheffold T, Kühl U, Schultheiss HP, Kreutz R, Ertl G, Angermann C, Charron P, Villard E, Gary F, Isnard R, Komajda M, Lutz M, Meitinger T, Sinner MF, Wichmann HE, Krawczak M, Ivandic B, Weichenhan D, Gelbrich G, El-Mokhtari NE, Schreiber S, Felix SB, Hasenfuß G, Pfeufer A, Hübner N, Kääb S, Arbustini E, Rottbauer W, Frey N, Stoll M, Katus HA. A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J. 2014;35(16):1069-77.
2013[ to top ]
  • Schowalter M, Gelbrich G, Störk S, Langguth JP, Morbach C, Ertl G, Faller H, Angermann CE. Generic and disease-specific health-related quality of life in patients with chronic systolic heart failure: impact of depression. Clin Res Cardiol. 2013;102(4):269-78.
  • Lossnitzer N, Herzog W, Störk S, Wild B, Müller-Tasch T, Lehmkuhl E, Zugck C, Regitz-Zagrosek V, Pankuweit S, Maisch B, Ertl G, Gelbrich G, Angermann CE. Incidence rates and predictors of major and minor depression in patients with heart failure. Int J Cardiol. 2013;167(2):502-7.
  • Reinsch N, Esser S, Gelbrich G, Brockmeyer N, Potthoff A, Schadendorf D, Erbel R, Neumann T. Valvular manifestations of human immunodeficiency virus infection--results from the prospective, multicenter HIV-HEART study. J Cardiovasc Med (Hagerstown). 2013;14(10):733-9.
  • Wachter R, Weber-Krüger M, Seegers J, Edelmann F, Wohlfahrt J, Wasser K, Gelbrich G, Hasenfuß G, Stahrenberg R, Liman J, Gröschel K. Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study. J Neurol. 2013;260(8):2042-5.
  • Lainscak M, Farkas J, Inkrot S, Gelbrich G, Neskovic AN, Rau T, Tahirovic E, Töpper A, Apostolovic S, Haverkamp W, Herrmann-Lingen C, Anker SD, Düngen HD. Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis. Int J Cardiol. 2013;163(1):87-92.
  • Edelmann F, Gelbrich G, Duvinage A, Stahrenberg R, Behrens A, Prettin C, Kraigher-Krainer E, Schmidt AG, Düngen HD, Kamke W, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Wachter R, Pieske B. Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial. Int J Cardiol. 2013;169(6):408-17.
  • Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, Löffler M, Düngen HD, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Pieske B, Investigators AD. Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction: The Aldo-DHF Randomized Controlled Trial. JAMA [Internet]. 2013;309(8):781-9. Available from: https://doi.org/10.1001/jama.2013.905
  • Esser S, Gelbrich G, Brockmeyer N, Goehler A, Schadendorf D, Erbel R, Neumann T, Reinsch N. Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study. Clin Res Cardiol. 2013;102(3):203-13.
  • Buder K, Gesierich A, Gelbrich G, Goebeler M. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives. Cancer Med. 2013;2(5):674-86.
2012[ to top ]
  • Angermann CE, Störk S, Gelbrich G, Faller H, Jahns R, Frantz S, Loeffler M, Ertl G, Failure CNH. Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail. 2012;5(1):25-3.
  • Lehmkuhl E, Kendel F, Gelbrich G, Dunkel A, Oertelt-Prigione S, Babitsch B, Knosalla C, Bairey-Merz N, Hetzer R, Regitz-Zagrosek V. Gender-specific predictors of early mortality after coronary artery bypass graft surgery. Clin Res Cardiol. 2012;101(9):745-51.
  • Stankovic I, Neskovic AN, Putnikovic B, Apostolovic S, Lainscak M, Edelmann F, Doehner W, Gelbrich G, Inkrot S, Rau T, Herrmann-Lingen C, Anker SD, Düngen HD. Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure--insight from the Cardiac Insufficiency Bisoprolol Study in Elderly. Int J Cardiol. 2012;161(3):160-5.
  • Loncar G, von Haehling S, Tahirovic E, Inkrot S, Mende M, Sekularac N, Lainscak M, Apostolovic S, Putnikovic B, Edelmann F, Wachter R, Dimkovic S, Waagstein F, Gelbrich G, Düngen HD. Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: results from the CIBIS-ELD trial. Clin Biochem. 2012;45(1-2):117-22.
  • Rau T, Düngen HD, Edelmann F, Waagstein F, Lainščak M, Dimković S, Apostolović S, Nešković AN, Haverkamp W, Gelbrich G, Eschenhagen T. Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients. Clin Pharmacol Ther. 2012;92(1):21-8.
  • Wachter R, Lahno R, Haase B, Weber-Krüger M, Seegers J, Edelmann F, Wohlfahrt J, Gelbrich G, Görlitz A, Kermer P, Vollmann D, Hasenfuß G, Gröschel K, Stahrenberg R. Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--the Find-AF study. PLoS One. 2012;7(4):e34351.
  • Edelmann F, Tomaschitz A, Wachter R, Gelbrich G, Knoke M, Düngen HD, Pilz S, Binder L, Stahrenberg R, Schmidt A, März W, Pieske B. Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction. Eur Heart J. 2012;33(2):203-12.
  • Dekleva M, Düngen HD, Gelbrich G, Incrot S, Suzic Lazic J, Pavlovic Kleut M, Tahirovic E, Waagstein F. Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure. CIBIS-ELD sub-study. Aging Clin Exp Res. 2012;24(6):675-81.
  • Hartwig M, Gelbrich G, Griewing B. Functional orthosis in shoulder joint subluxation after ischaemic brain stroke to avoid post-hemiplegic shoulder-hand syndrome: a randomized clinical trial. Clin Rehabil. 2012;26(9):807-16.
  • Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, de Brouwer S, Perrin E, Baumann G, Gelbrich G, Boll H, Honold M, Koehler K, Kirwan BA, Anker SD. Telemedicine in heart failure: pre-specified and exploratory subgroup analyses from the TIM-HF trial. Int J Cardiol. 2012;161(3):143-50.
  • Gelbrich G, Edelmann F, Inkrot S, Lainscak M, Apostolovic S, Neskovic AN, Waagstein F, Loeffler M, Anker SD, Dietz R, Düngen HD. Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly. Int J Cardiol. 2012;155(1):160-6.
  • Zugck C, Franke J, Gelbrich G, Frankenstein L, Scheffold T, Pankuweit S, Duengen HD, Regitz-Zagrosek V, Pieske B, Neumann T, Rauchhaus M, Angermann CE, Katus HA, Ertl GE, Störk S. Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure. Clin Res Cardiol. 2012;101(4):263-72.